Reducing large proteins to small molecules yields more affordable drugs

Dec 05, 2013 by Bronwyn Adams
Reducing large proteins to small molecules yields more affordable drugs
Dr Bob Reid

(Phys.org) —University of Queensland researchers have pioneered a drug development technique that could pave the way for a new class of low-cost medicines.

The researchers, led by Professor David Fairlie and Dr Robert Reid from UQ's Institute for Molecular Bioscience (IMB), designed a technique that reduces large proteins to small molecules suitable for use as drugs.

Professor Fairlie said the result was a smaller, more affordable version of a powerful human inflammatory , complement protein C3a, that helps defend against disease.

C3a costs thousands of dollars per milligram to manufacture commercially and degrades in minutes in blood, making it too expensive and unstable to be easily used in medicines.

The researchers have designed a small molecule that retains the same potent activities of C3a but is much cheaper and more stable for .

"Despite the importance of proteins to nearly every function in the body, their use in science, industry and medicine is significantly restricted by their high cost and instability," Professor Fairlie said.

"A holy grail in chemistry has been to find a way to reduce large proteins down to much smaller, simpler and cheaper molecules with the same activities.

"We have done exactly that, opening up exciting new avenues for chemists to downsize valuable human proteins and obtain affordable new diagnostics and drugs for the detection and treatment of human diseases," he said.

Dr Reid said the team had identified the key components of the protein that fought disease.

"We have developed a way of using chemical scaffolds to control the molecule's shape and reproduce protein functionhe said.

The research, published in leading scientific journal Nature Communications, was supported by the National Health and Medical Research Council and the Australian Research Council.

Explore further: Killer sea snail a target for new drugs

Related Stories

New research shows obesity is an inflammatory disease

Dec 02, 2013

Scientists have moved a step closer to an "obesity drug" that may block the effects of diets high in sugar and fats. In a new research report published in the December 2013 issue of The FASEB Journal, scientists show that t ...

New family of proteins linked to major role in cancer

Dec 01, 2013

(Medical Xpress)—Scientists have described a new family of proteins that appear to play a key role in cancer and might be targets for future cancer drugs. A major new study in the journal Nature sets out the structure of the ...

Recommended for you

Killer sea snail a target for new drugs

19 hours ago

University of Queensland pain treatment researchers have discovered thousands of new peptide toxins hidden deep within the venom of just one type of Queensland cone snail.

How cancer cells avoid shutdown

Jul 06, 2015

A mechanism beyond the level of gene regulation, which is often the underlying reason for changes in protein levels, does enable the strong accumulation of a tumour promoting protease in stressed cancer cells. ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.